dutasteride mesotherapy
Selected indexed studies
- Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice. (J Drugs Dermatol, 2022) [PMID:35816059]
- Mesotherapy with dutasteride for androgenetic alopecia: a concise review of the literature. (Eur J Dermatol, 2023) [PMID:37178048]
- Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. (Dermatology, 2024) [PMID:39278205]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. (2024) pubmed
- Mesotherapy with dutasteride for androgenetic alopecia: a concise review of the literature. (2023) pubmed
- Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice. (2022) pubmed
- Systematic review of mesotherapy: a novel avenue for the treatment of hair loss. (2023) pubmed
- Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial. (2025) pubmed
- RF-Mesotherapy With Dutasteride: A Future Alternative Treatment for Androgenetic Alopecia. (2020) pubmed
- Outcomes of androgenetic alopecia treated with dutasteride mesotherapy: A case series. (2024) pubmed
- Comparative Efficacy of Minoxidil and 5-Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta-Analysis Study of Current Empirical Evidence. (2025) pubmed
- Paradoxical Nonscarring Alopecia Following Mesotherapy with Dutasteride: A Case Series. (2025) pubmed
- Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia. (2017) pubmed